Uncategorized

Trump’s pharma tariffs: Sun Pharma, Cipla to Dr Reddy’s — why experts see a sharp rebound on Monday? EXPLAINED

Trump’s pharma tariffs: Analysts believe Indian pharma companies, primarily focused on generics, will largely avoid impact due to the tariffs being aimed at branded drugs

Leave a Comment

Your email address will not be published. Required fields are marked *

Invest Now
Scroll to Top